Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action
- 30 June 1983
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 32 (6) , 571-580
- https://doi.org/10.1016/0026-0495(83)90027-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Changes in body composition following therapy of osteoporosis with methandrostenoloneMetabolism, 1981
- Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral massMetabolism, 1977
- Relationship between local and total bone mass in osteoporosisMetabolism, 1975
- Quantitative Histological Studies on the Pathogenesis of Uremic Bone Disease*Journal of Clinical Endocrinology & Metabolism, 1974
- Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosisJournal of Clinical Investigation, 1972
- Effect of treatment of calcium kinetics in metabolic bone diseaseMetabolism, 1971
- Radioimmunoassay of human parathyroid hormone in serumJournal of Clinical Investigation, 1971
- Urinary polypeptides related to collagen synthesisJournal of Clinical Investigation, 1970
- Effects of androgens, estrogens and high calcium intakes on bone formation and resorption in osteoporosisThe American Journal of Medicine, 1964
- A specific method for the analysis of hydroxyproline in tissues and urineAnalytical Biochemistry, 1960